New amide compounds as boosters of antivirals

Details for Australian Patent Application No. 2009301131 (hide)

Owner Tibotec Pharmaceuticals

Inventors Jonckers, Tim Hugo Maria; Schepens, Wim Bert Griet; Hache, Geerwin Yvonne Paul; Hallenberger, Beate Sabine; Sasaki, Jennifer Chiyomi; Baumeister, Judith Eva; Van 'T Klooster, Gerben Albert Eleutherius

Agent Shelston IP

Pub. Number AU-A-2009301131

PCT Pub. Number WO2010/040762

Priority 08166004.5 07.10.08 EP

Filing date 7 October 2009

Wipo publication date 15 April 2010

International Classifications

C07D 277/24 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/040762 Priority application(s): WO2010/040762

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301132-Process to prepare a gas mixture of hydrogen and carbon monoxide

2009301125-Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6